No Detail Found!

Burden of Syndrome X among Females in Karachi, Pakistan.

Author(s)
Zuneera Akram Department of Pharmacology, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
Muzammil Hussain Department of Pharmacology, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
Sadaf Ibrahim Department of Pharmacology, Faculty of Pharmacy, Ziauddin University, Karachi, Pakistan
Mariam Razzak Department of Pharmacology, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
Rehana Perveen Department of Pharmacology, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
Aisha Noreen Department of Pharmaceutical Chemistry, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
Zobia Zia Department of Pharmacology, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
Abstract
Aim: The co-relation of hypertension with hyperglycemic indicates the allocation of a common physiologic predecessor, suggested to be insulin tissue resistance. Insulin resistance is associated with a number of risk factors, identified and acknowledged as a metabolic syndrome or Syndrome X. Syndrome X is a term instead of a disease itself, used to emphasize determinants that increases the possibilities of cardiovascular disorders to approximately 2 times and for type II diabetes to 5 times. Objective: The main objective of this study is to estimate the risk of Syndrome X among the females of Pakistan as well as the suggestions to control the spreading of the syndrome through advising proper lifestyle changes. Methods: A random sampling method was used to do population-based cross-sectional study among 150 out of 280 women aged 35-55 years. Pregnant female and those who didn't fast for 8-12 hours were excluded from all analyses. The data was obtained via percentage system. Results: The national survey conducted implied that the metabolic syndrome is now very common in Pakistan, affecting about 30.66% and 56% (based on classification of amended guidelines of NCEP, and IDF respectively) of female population of age group of 35-55 years, being more common in women than above age of 50 years. Conclusions: Syndrome X spread because of age factor and obesity as well as due to diabetes type II, hypertension and dyslipidemia. Adding exercise and diet to instigate weight loss in life the foundation of treatment. Atherogenic dyslipidemia, hypertension, and hyperglycaemia are treated with pharmacological involvement.
Publication Details
Page(s) 178-184
DOI DOI not available
Published Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 6, Issue: 3, Year: 2018

Request the full text from PASTIC

Keywords
Metabolic syndrome, insulin tissue resistance, hyperglycaemia
References
AlbertiKG,EckelRH,GrundySM,ZimmetPZ,CleemanJI,DonatoKA, 2009.Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung,,International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120 1640 -5
KaurJ., 2014.A comprehensive review on metabolic syndrome,Cardiol Res Pract 943162 -
WilsonPW,D'AgostinoRB,PariseH,SullivanL,MeigsJB, 2005.Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus,Circulation 112 3066 -72
RitchieSA,ConnellJMC, 2007.The link between abdominal obesity, metabolic syndrome and cardiovascular disease,Nutr Metab Cardiovasc Dis 17 319 -26
KylinE., 1923.Studien ueber das Hypertonie-Hyperglyca “mie-Hyperurika” miesyndrom,Zentralblatt fuer Innere Medizin 44 105 -27
VagueJ, 1947.Sexual differentiation. A factor affecting the forms of obesity,Presse Medicale 30 39 -40
AvogaroP,CrepaldiG, 1965.Essential hyperlipidemia, obesity and diabetes,Diabetologia 1 137 -
ReavenGM, 1988.Role of insulin resistance in human disease,Diabetes 37 1595 -607
KaplanNM., 1989.The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension,Arch Intern Med 149 1514 -20
HaffnerSM,ValdezRA,HazudaHP,MitchellBD,MoralesPA,SternMP, 1992.Prospective analysis of the insulin-resistance syndrome (Syndrome X), 41 715 -22
AlbertiKG,ZimmetPZ, 1998.Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation,Diabetic Med 15 539 -53
BalkauB,CharlesMA, 1999.Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR),Diabetic Med 16 442 -3
2001.Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III),In Third Report of the National Cholesterol Education Program Expert Panel on Detection -
CleemanJI, 2001.Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),J Am Med Assoc 285 2486 -97
EinhornD,ReavenGM,CobinRH,FordE,GandaOP,HandelsmanY, 2003.American College of Endocrinology position statement on the insulin resistance syndrome,Endocr Pract 9 237 -52
FordES, 2004.Prevalence of the metabolic syndrome in US populations,Endocrinol Metab Clin North Am 33 333 -50
2005.The IDF consensus worldwide definition of the metabolic syndrome,pdf. Accessed 2 September -
GamiAS,WittBJ,HowardDE,ErwinPJ,GamiLA,SomersVK,MontoriVM, 2007.Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies,J Am Coll Cardiol 49 403 -14
Fernandez-MendozaJ,HeF,LaGrotteC,VgontzasAN,LiaoD,BixlerEO, 2017.Impact of the Metabolic Syndrome on Mortality is Modified by Objective Short Sleep Duration,pii: e002182. 6 -
2005.Centers for Disease Control, 02 -2004
RaposoL,SeveroM,SantosAC, 2018.Adiposity cut-off points for cardiovascular disease and diabetes risk in the Portuguese population: The PORMETS study,PLoS One 13 e0191641 -
ChinawaleCG,ParmarDV,KavathiaP,RangnaniT,ThakkarJ,KarthaG, 2018.Metabolic Syndrome among Adults of Surendranagar District of Saurashtra, Gujarat: A Cross-Sectional Study,Indian J Community Med 43 24 -8
DrehmerM,OdegaardAO,SchmidtMI,DuncanBB,CardosoLO,MatosSMA, 2017.Brazilian dietary patterns and the dietary approaches to stop hypertension (DASH) diet-relationship with metabolic syndrome and newly diagnosed diabetes in the ELSA-Brasil study,Diabetol Metab Syndr 9 13 -
MensahGA,MokdadAH,FordES,GreenlundKJ,CroftJB, 2005.State of disparities in cardiovascular health in the United States,Circulation 111 1233 -41
OgdenCL,CarrollMD,KitBK,FlegalKM, 2014.Prevalence of childhood and adult obesity in the United States,, 311 806 -14
FordES, 2005.Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U, 28 2745 -9
MehrdadR,PouryaghoubG,MoradiM., 2018.Association between Metabolic Syndrome and Job Rank,Int J Occup Environ Med 9 45 -51
DiabetesManagement, .-areas/diabetes/guidelines-and-goals., -
GrundySM,HansenB,SmithSC,CleemanJI,KahnRA., 2004.on scientific issues related to management,Arterioscler Thromb Vasc Biol 24 e19 -24
MartinKA,ManiMV,ManiA,PtA, 2015.New targets to treat obesity and the metabolic syndrome,Eur J Pharmacol 763 64 -74
GulatiM., .A combination of certain conditions can double risk for heart disease, -
FordES,GilesWH,MokdadAH, 2004.Increasing prevalence of the metabolic syndrome among U.S. adults,Diabetes Care 27 2444 -9
2006.Ministry of Health and Welfare of Korea. The Third Korea National Health and Nutrition Examination Survey (KNHANESIII) 2005, -
PanditK,GoswamiS,GhoshS,MukhopadhyayP,ChowdhuryS., 2012.Metabolic syndrome in South Asians,Indian J Endocrinol Metab 16 44 -55
MabryRM,ReevesMM,EakinEG,OwenN., 2010.Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review,Diabetic Med 27 593 -7
LimDM,ParkKY,KimBJ, 2009.Cardiovascular risk according to the components of metabolic syndrome in type 2 diabetes,Korean Diabetes J 10 196 -203
GuptaM,Brister S. Is South, 2006.Asian ethnicity an independent cardiovascular risk factor?,Can J Cardiol 22 193 -7
RamachandranA,MaryS,YamunaA,MurugesanN,SnehalathaC, 2008.High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India,Diabetes Care 31 893 -8
JafarTH, 2006.Women in Pakistan have a greater burden of clinical cardiovascular risk factors than men,Int J Cardiol 106 348 -54
NelsonK,NorrisK,MangioneCM, 2002.Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey,Arch Intern Med 162 929 -35
NakagamiT,QiaoQ,TuomilehtoJ,BalkauB,TajimaN,HuG, 2006.Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study,Eur J Cardiovasc Prev Rehabil 13 555 -61
0

Citations

0

Downloads

41

Views